03/14/2025
Leverage the Power of Hybrid-capture HLA Typing with New AlloSeq Assign
03/14/2025
AlloSure Specimen Collection and Shipping Instructions Video
09/10/2024
CareDx Journal Club: Cell-Free DNA for the Detection of Kidney Allograft Rejection
07/23/2024
HeartCare Interpretive Pocket Guide
07/23/2024
The Surveillance HeartCare Outcomes Registry (SHORE)
07/23/2024
Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes…
06/03/2024
From Invasive to Intelligent: Utilizing Cutting-Edge Artificial Intelligence and Molecular Diagnostics in…
03/14/2024
Heartcare Interpretive Guide
10/19/2023
One Size Can Fit All: AlloCell – the Universal Assay for Pharmacokinetics (PK) Monitoring of Allogeneic…
09/17/2023
ESOT 2023: Adopting dd-cfDNA for Solid Organ Surveillance: Raising the Standards of Transplant Care
07/20/2023
Virtual Crossmatching and Epitope Analysis As Informational Aids in the Transplant Decision Making Process: A…
11/16/2022
The Proof is in the Metrics – AlloSeq HCT Case Studies
11/07/2022
Comprehensive HCT Software Quality Metrics – Advanced Training
10/19/2022
Streamlined Detection of Chimerism Using NGS – Advances of AlloSeq HCT Assay
10/12/2022
AlloSeq HCT: The Future of Chimerism Testing – Leading Change by Next Generation Sequencing
08/22/2022
Tackling Health Equity in Organ Transplantation
07/20/2022
Merge Ahead: The New OPO Landscape & Ways Your OPO Can Prepare
06/29/2022
Regional Webinar Series: Surveillance of dd-cDNA by Next Generation Sequencing – AlloSeq cDNA Practical…
05/31/2022
ATC 2022 Abstracts List
04/27/2022
2022 HLA Webinar Series: Investigation and Submission of Novel Alleles
03/29/2022
AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
03/02/2022
Score 6 Advanced Options and Troubleshooting Tips – Fast Results with Automated Analysis
01/26/2022
Transplant Quality Outcomes – Part 2: Leveraging New & Existing Tools to Manage Your Quality Outcomes:…
01/19/2022
Managing Your Outcomes in a World of Imperfect Organs and Higher Risk Recipients